90
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Investigating the progression of preeclampsia through a comprehensive analysis of genes associated with per- and polyfluoroalkyl substances

, &
Pages 444-453 | Received 27 Sep 2023, Accepted 19 Dec 2023, Published online: 02 Jan 2024

References

  • Begley TH, White K, Honigfort P, Twaroski ML, Neches R, Walker RA. 2005. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam. 22(10):1023–1031. doi:10.1080/02652030500183474.
  • Bensinger SJ, Tontonoz P. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 454(7203):470–477. doi:10.1038/nature07202.
  • Blake BE, Cope HA, Hall SM, Keys RD, Mahler BW, McCord J, Scott B, Stapleton HM, Strynar MJ, Elmore SA, et al. 2020. Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX). Environ Health Perspect. 128(2):27006. doi:10.1289/EHP6233.
  • Blake BE, Fenton SE. 2020. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri- and postnatal effects. Toxicology. 443:152565. doi:10.1016/j.tox.2020.152565.
  • Blitek A, Szymanska M. 2020. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation. Theriogenology. 152:36–46. doi:10.1016/j.theriogenology.2020.04.024.
  • Bommarito PA, Ferguson KK, Meeker JD, McElrath TF, Cantonwine DE. 2021. Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk. Environ Health Perspect. 129(10):107004. doi:10.1289/EHP9091.
  • Brunmeir R, Xu F. 2018. Functional Regulation of PPARs through Post-Translational Modifications. Int J Mol Sci. 19(6):1738. doi:10.3390/ijms19061738.
  • Chang MC, Chung SM, Kwak SG. 2023. Exposure to perfluoroalkyl and polyfluoroalkyl substances and risk of stroke in adults: a meta-analysis. Rev Environ Health. doi:10.1515/reveh-2023-0021.
  • Cirkovic A, Garovic V, Milin Lazovic J, Milicevic O, Savic M, Rajovic N, Aleksic N, Weissgerber T, Stefanovic A, Stanisavljevic D, et al. 2020. Systematic review supports the role of DNA methylation in the pathophysiology of preeclampsia: a call for analytical and methodological standardization. Biol Sex Differ. 11(1):36. doi:10.1186/s13293-020-00313-8.
  • Costello E, Rock S, Stratakis N, Eckel SP, Walker DI, Valvi D, Cserbik D, Jenkins T, Xanthakos SA, Kohli R, et al. 2022. Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: a Systematic Review and Meta-Analysis. Environ Health Perspect. 130(4):46001. doi:10.1289/EHP10092.
  • Davis AP, Wiegers TC, Johnson RJ, Sciaky D, Wiegers J, Mattingly CJ. 2023. Comparative Toxicogenomics Database (CTD): update 2023. Nucleic Acids Res. 51(D1):D1257–d1262. doi:10.1093/nar/gkac833.
  • Deer E, Herrock O, Campbell N, Cornelius D, Fitzgerald S, Amaral LM, LaMarca B. 2023. The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol. 19(4):257–270. doi:10.1038/s41581-022-00670-0.
  • Dhore R, Murthy GS. 2021. Per/polyfluoroalkyl substances production, applications and environmental impacts. Bioresour Technol. 341:125808. doi:10.1016/j.biortech.2021.125808.
  • Diao C, Xi Y, Xiao T. 2018. Identification and analysis of key genes in osteosarcoma using bioinformatics. Oncology Letters. 15(3):2789–2794.
  • Ding X, Yang Z, Han Y, Yu H. 2014. Adverse factors increase preeclampsia-like changes in pregnant mice with abnormal lipid metabolism. Chinese Medical Journal. 127(15):2814–2818.
  • Erinc A, Davis MB, Padmanabhan V, Langen E, Goodrich JM. 2021. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy. Environ Res. 197:111113. doi:10.1016/j.envres.2021.111113.
  • Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 20(3):307–315. doi:10.1093/bioinformatics/btg405.
  • Hashemi V, Dolati S, Hosseini A, Gharibi T, Danaii S, Yousefi M. 2017. Natural killer T cells in Preeclampsia: an updated review. Biomed Pharmacother. 95:412–418. doi:10.1016/j.biopha.2017.08.077.
  • Huo X, Huang R, Gan Y, Luo K, Aimuzi R, Nian M, Ao J, Feng L, Tian Y, Wang W, et al. 2020. Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study. Environ Int. 138:105656. doi:10.1016/j.envint.2020.105656.
  • Jiang H, Liu H, Liu G, Yu J, Liu N, Jin Y, Bi Y, Wang H. 2022. Associations between Polyfluoroalkyl Substances Exposure and Breast Cancer: A Meta-Analysis. Toxics. 10(6):318. doi:10.3390/toxics10060318.
  • Khaire AA, Thakar SR, Wagh GN, Joshi SR. 2021. Placental lipid metabolism in preeclampsia. J Hypertens. 39(1):127–134. doi:10.1097/HJH.0000000000002596.
  • Kim S, Thapar I, Brooks BW. 2021. Epigenetic changes by per- and polyfluoroalkyl substances (PFAS). Environ Pollut. 279:116929. 116929. doi:10.1016/j.envpol.2021.116929.
  • Miková E, Hrdý J. 2020. The role of neutrophils in preeclampsia. Ceska Gynekologie. 85(3):206–213.
  • Mor G. 2022. Introduction to the immunology of pregnancy. Immunol Rev. 308(1):5–8. doi:10.1111/imr.13102.
  • Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. 2021. Vascular Dysfunction in Preeclampsia. Cells. 10(11):3055. doi:10.3390/cells10113055.
  • Pham A, Zhang J, Feng L. 2020. Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast. Reprod Toxicol. 98:269–277. doi:10.1016/j.reprotox.2020.10.013.
  • Pique-Regi R, Romero R, Tarca AL, Sendler ED, Xu Y, Garcia-Flores V, Leng Y, Luca F, Hassan SS, Gomez-Lopez N. 2019. Single cell transcriptional signatures of the human placenta in term and preterm parturition. Elife. 8:e52004. doi:10.7554/eLife.52004.
  • Psilopatis I, Vrettou K, Fleckenstein FN, Theocharis S. 2023. The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia. Cells. 12(4):647. doi:10.3390/cells12040647.
  • Roth K, Petriello MC. 2022. Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk. Front Endocrinol (Lausanne). 13:965384. 965384. doi:10.3389/fendo.2022.965384.
  • Rylander L, Lindh CH, Hansson SR, Broberg K, Källén K. 2020. Per- and Polyfluoroalkyl Substances in Early Pregnancy and Risk for Preeclampsia: A Case-Control Study in Southern Sweden. Toxics. 8(2):43. doi:10.3390/toxics8020043.
  • Sanguansermsri D, Pongcharoen S. 2008. Pregnancy immunology: decidual immune cells. Asian Pacific Journal of Allergy and Immunology. 26(2-3):171–181.
  • Savitz DA, Klebanoff MA, Wellenius GA, Jensen ET, Longnecker MP. 2014. Persistent organochlorines and hypertensive disorders of pregnancy. Environ Res. 132:1–5. doi:10.1016/j.envres.2014.03.020.
  • Soljic V, Barbaric M, Vukoja M, Curlin M, Orlovic Vlaho M, Cerni Obrdalj E, Lasic Arapovic L, Bevanda Glibo D, Vukojevic K. 2021. Decreased Expression of Cytotoxic Proteins in Decidual CD8(+) T Cells in Preeclampsia. Biology (Basel). 10(10):1037. doi:10.3390/biology10101037.
  • Szilagyi JT, Avula V, Fry RC. 2020. Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator-Activated Receptors (PPARs). Curr Environ Health Rep. 7(3):222–230. doi:10.1007/s40572-020-00279-0.
  • Szilagyi JT, Freedman AN, Kepper SL, Keshava AM, Bangma JT, Fry RC. 2020. Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro. Toxicol Sci. 175(2):210–219. doi:10.1093/toxsci/kfaa043.
  • Tian Y, Yang J, Lan M, Zou T. 2020. Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure. Aging (Albany NY). 12(24):26221–26235. doi:10.18632/aging.202405.
  • Tian Y, Zhou Q, Zhang L, Li W, Yin S, Li F, Xu C. 2023. In utero exposure to per-/polyfluoroalkyl substances (PFASs): preeclampsia in pregnancy and low birth weight for neonates. Chemosphere. 313:137490. 137490. doi:10.1016/j.chemosphere.2022.137490.
  • Tibshirani R. 1997. The lasso method for variable selection in the Cox model. Statist Med. 16(4):385–395. doi:10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3.
  • Trogstad L, Magnus P, Stoltenberg C. 2011. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol. 25(3):329–342. doi:10.1016/j.bpobgyn.2011.01.007.
  • Vestergren R, Cousins IT, Trudel D, Wormuth M, Scheringer M. 2008. Estimating the contribution of precursor compounds in consumer exposure to PFOS and PFOA. Chemosphere. 73(10):1617–1624. doi:10.1016/j.chemosphere.2008.08.011.
  • Wang Y, Wang K, Han T, Zhang P, Chen X, Wu W, Feng Y, Yang H, Li M, Xie B, et al. 2020. Exposure to multiple metals and prevalence for preeclampsia in Taiyuan, China. Environ Int. 145:106098. 106098. doi:10.1016/j.envint.2020.106098.
  • Wang Z, DeWitt JC, Higgins CP, Cousins IT. 2017. A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)? Environ Sci Technol. 51(5):2508–2518. doi:10.1021/acs.est.6b04806.
  • Xu Q, Chen S, Hu Y, Huang W. 2021. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer. Front Immunol. 12:711433. 711433. doi:10.3389/fimmu.2021.711433.
  • Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, et al. 2013. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 4(1):2612. doi:10.1038/ncomms3612.
  • Yu G, Wang LG, Han Y, He QY. 2012. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16(5):284–287. doi:10.1089/omi.2011.0118.
  • Yu H, Yin Y, Zhang J, Zhou R. 2020. The impact of particulate matter 2.5 on the risk of preeclampsia: an updated systematic review and meta-analysis. Environ Sci Pollut Res Int. 27(30):37527–37539. doi:10.1007/s11356-020-10112-8.
  • Zheng G, Salamova A. 2020. Are Melamine and Its Derivatives the Alternatives for Per- and Polyfluoroalkyl Substance (PFAS) Fabric Treatments in Infant Clothes? Environ Sci Technol. 54(16):10207–10216. doi:10.1021/acs.est.0c03035.
  • Zhou W, Wang H, Yang Y, Guo F, Yu B, Su Z. 2022. Trophoblast Cell Subtypes and Dysfunction in the Placenta of Individuals with Preeclampsia Revealed by Single‑Cell RNA Sequencing. Mol Cells. 45(5):317–328. doi:10.14348/molcells.2021.0211.
  • Zhou Y, Shi W, Zhao D, Xiao S, Wang K, Wang J. 2022. Identification of Immune-Associated Genes in Diagnosing Aortic Valve Calcification With Metabolic Syndrome by Integrated Bioinformatics Analysis and Machine Learning. Front Immunol. 13:937886. doi:10.3389/fimmu.2022.937886.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.